Novo Nordisk Foundation
Female Heart Clinical Mechanistic Research Grants
Phase 1 concept note deadline not specified in this segment; applicants notified in April for Phase 2 invitation
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | DKK 10M–15M per grant (total pool up to DKK 75M) |
| Duration | 3–5 years |
| Consortium | Required — main applicant in a Nordic country (DK, SE, NO, FI, IS); at least one co-applicant outside main applicant's country, anchored at EEA/UK/Swiss non-profit institution |
| Application | 2-stage: Phase 1 concept note → Phase 2 full application with external peer review |
| Eligible countries | DKSENOFIIS |
Eligibility & scope
Main applicant must be at a Nordic university, hospital, or non-profit research institution with primary employment there. Co-applicants must be at EEA/UK/Swiss non-profit institutions; at least one must be outside the main applicant's country. International collaboration is mandatory — same-country-only teams are ineligible. Focuses on female heart clinical mechanistic research.
More from Novo Nordisk Foundation
Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4 million per grantNovo Nordisk Foundation Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4M (~€2.6M)Steno Collaborative Grants
Deadline: 2 Jun 2026DKK 1M–DKK 10M per grant (total pool up to DKK 30M)Non-Diabetic Endocrinology Collaborative Grants 2026
Deadline: 3 Jun 2026DKK 5M–10M per grant (total pool up to DKK 53M)Project grants in Endocrinology and Metabolism – Nordic Region
Deadline: 4 Jun 2026Up to DKK 4.5 million per grant
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free